Exhibit 1.1
EXECUTION COPY
AMEREN CORPORATION
$425,000,000
8.875% SENIOR NOTES DUE
2014
Underwriting
Agreement
May 12, 2009
BNP Paribas Securities Corp.
787 Seventh Avenue
New York, New York 10019
J.P. Morgan Securities Inc.
270 Park Avenue
New York, New York 10017
UBS Securities LLC
677 Washington Boulevard
Stamford, Connecticut 06901
As Representatives of the several
Underwriters named in Schedule I
hereto
Ladies and Gentlemen:
Ameren Corporation, a Missouri
corporation (the Company ), proposes, subject to the
terms and conditions stated herein, to issue and sell to the
underwriters named in Schedule I hereto (the
Underwriters ), for whom BNP Paribas Securities Corp,
J.P. Morgan Securities Inc. and UBS Securities LLC are acting as
representatives (in such capacity, the
Representatives ), an aggregate of $425,000,000
principal amount of the Company’s 8.875% Senior Notes due
2014 (the Securities ).
1.
The Company represents and warrants
to, and agrees with, each of the Underwriters that:
(a)
The Company meets the requirements
for the use of an “automatic shelf registration
statement”, as defined under Rule 405 under the
Securities Act of 1933, as amended (the 1933 Act ),
and such registration statement on Form S-3 (File
No. 333-155416) in respect of the Securities has been filed
with the Securities and Exchange Commission (the SEC
) not earlier than three years prior to the date hereof; such
registration statement, and any post-effective amendment thereto,
became effective on filing with the SEC; and no stop order
suspending the effectiveness of such registration statement, any
post-effective amendment thereto or any part thereof has been
issued and no proceeding for that purpose or pursuant to
Section 8A of the 1933 Act against the Company or relating to
the offering of the Securities has been initiated or threatened by
the SEC, and no notice of objection of the SEC to the use of such
registration statement or any post-effective amendment thereto
pursuant to Rule 401(g)(2)
under the 1933 Act has been received by the
Company (any prospectus related to the Company included in such
registration statement at the time it became effective that omits
Rule 430 Information (as defined herein) or any preliminary
prospectus supplement (together with the accompanying prospectus)
used in connection with the offering and sale of the Securities
that is deemed to be part of and included in such registration
statement pursuant to Rule 430B(e) under the 1933 Act, is
hereinafter called a Preliminary Prospectus ); the
various parts of such registration statement and any post-effective
amendment thereto, including all exhibits thereto and the documents
incorporated by reference in the prospectus contained in such
registration statement at the time such part of such registration
statement became effective but excluding any Form T-1, each as
amended at the time such part of such registration statement became
effective, and including any information omitted from such
registration statement at the time such part of such registration
statement became effective but that is deemed to be part of such
registration statement pursuant to Rule 430A, Rule 430B
or Rule 430C under the 1933 Act at the time set forth therein
( Rule 430 Information ) are hereinafter
collectively called the Registration Statement ; the
prospectus and prospectus supplement in the form first used (or
made available upon request of purchasers pursuant to Rule 173
under the 1933 Act) in connection with confirmation of sales of the
Securities and filed by the Company with the SEC pursuant to
Rule 424(b) under the 1933 Act in accordance with
Section 5(a) hereof is hereinafter called the
Prospectus ; any reference herein to the Registration
Statement, any Preliminary Prospectus or the Prospectus shall be
deemed to refer to and include the documents incorporated by
reference therein pursuant to the applicable form under the 1933
Act, as of the effective date of the Registration Statement
applicable to the Company and for the Securities pursuant to
Rule 430B(f)(2) under the 1933 Act, the date of such
Preliminary Prospectus or the date of the Prospectus, as the case
may be; any reference to any amendment or supplement to the
Registration Statement, any Preliminary Prospectus or the
Prospectus shall be deemed to include any documents filed after the
effective date of the Registration Statement or the date of such
Preliminary Prospectus or the date of the Prospectus, as the case
may be, under the Securities Exchange Act of 1934, as amended (the
1934 Act ), and the rules and regulations of the
SEC thereunder, and incorporated by reference in the
Registration Statement, such Preliminary Prospectus or the
Prospectus, as the case may be.
(b)
No order preventing or suspending
the use of any Preliminary Prospectus or any “issuer free
writing prospectus” as defined in Rule 433 under the
1933 Act relating to the Securities (hereinafter called an
Issuer Free Writing Prospectus ) has been issued by
the SEC, and each Preliminary Prospectus, at the time of filing
thereof, conformed in all material respects to the requirements of
the 1933 Act and the Trust Indenture Act of 1939, as amended (the
1939 Act ), and the rules and regulations of the
SEC thereunder, and did not contain an untrue statement of a
material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein, in the
light of the circumstances under which they were made, not
misleading; provided, however, that this representation and
warranty shall not apply to any statements or omissions made in
reliance upon and in conformity with information furnished in
writing to the Company by an Underwriter through the
Representatives expressly for use therein.
(c)
For the purposes of this Agreement,
the Applicable Time is 5:30 p.m., New York City
time, on the date of this Agreement; a Preliminary Prospectus dated
May 12, 2009, as amended or supplemented immediately prior to
the Applicable Time (including the documents incorporated therein
by reference as of the Applicable Time) (the Pricing
Prospectus ) as supplemented by the final term sheet
prepared and filed pursuant to Section 5(a) hereof, taken
together (collectively, the Pricing Disclosure
Package ) as of the Applicable
2
Time and as of the Time of Delivery (as defined
herein), did not and will not include any untrue statement of a
material fact or omit to state any material fact necessary in order
to make the statements therein, in the light of the circumstances
under which they were made, not misleading; and each Issuer Free
Writing Prospectus listed on Schedule II(b) hereto does
not conflict with the information contained in the Registration
Statement, the Pricing Prospectus or the Prospectus and each such
Issuer Free Writing Prospectus, as supplemented by and taken
together with the Pricing Disclosure Package as of the Applicable
Time, did not include any untrue statement of a material fact or
omit to state any material fact necessary in order to make the
statements therein, in the light of the circumstances under which
they were made, not misleading; provided, however, that this
representation and warranty shall not apply to statements or
omissions made in an Issuer Free Writing Prospectus in reliance
upon and in conformity with information furnished in writing to the
Company by an Underwriter through the Representatives expressly for
use therein.
(d)
The documents incorporated by
reference in the Registration Statement, the Pricing Disclosure
Package or the Prospectus, when they became effective or were filed
with the SEC, as the case may be, conformed in all material
respects to the requirements of the 1933 Act or the 1934 Act, as
applicable, and the rules and regulations of the SEC
thereunder, and none of such documents contained any untrue
statement of a material fact or omitted to state a material fact
required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were
made, not misleading; and any further documents so filed and
incorporated by reference in the Registration Statement, the
Pricing Disclosure Package or the Prospectus or any further
amendment or supplement thereto, when such documents become
effective or are filed with the SEC, as the case may be, will
conform in all material respects to the requirements of the 1933
Act or the 1934 Act, as applicable, and the rules and
regulations of the SEC thereunder and will not contain any untrue
statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were
made, not misleading; provided, however, that this representation
and warranty shall not apply to any statements or omissions made in
reliance upon and in conformity with information furnished in
writing to the Company by an Underwriter through the
Representatives expressly for use therein; and no such documents
were filed with the SEC since the SEC’s close of business on
the business day immediately prior to the date of this Agreement
and prior to the execution of this Agreement, except as set forth
on Schedule II(c) hereto.
(e)
The Registration Statement, the
Pricing Prospectus and the Prospectus conform, and any further
amendments or supplements to the Registration Statement, the
Pricing Prospectus or the Prospectus will conform, in all material
respects to the requirements of the 1933 Act and the 1939 Act and
the rules and regulations of the SEC thereunder and do not and
will not, as of the latest date as of which any part of the
Registration Statement relating to the Securities became, or is
deemed to have become, effective under the 1933 Act in accordance
with the rules and regulations of the SEC thereunder as to the
Registration Statement and any amendment thereto, and as of their
respective dates as to the Pricing Prospectus and the Prospectus
and any amendment or supplement thereto, respectively, and as of
the Time of Delivery as to the Prospectus, contain an untrue
statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements
therein not misleading; provided, however, that this representation
and warranty shall not apply to any statements or omissions made in
reliance upon and in conformity with information furnished in
writing to the Company by an Underwriter through the
Representatives expressly for use in the Registration Statement,
the Pricing Prospectus or the Prospectus.
3
(f)
The Securities have been duly
authorized by the Company for issuance and sale to the Underwriters
pursuant to this Agreement and, when executed and authenticated in
accordance with the provisions of the Indenture (as defined below)
and issued and delivered by the Company pursuant to this Agreement
against payment of the consideration set forth herein, will
constitute valid and legally binding obligations of the Company,
enforceable against the Company in accordance with their terms and
the terms of the Indenture, subject to the Exceptions (as defined
below), and entitled to the benefits provided by the indenture,
dated as of December 1, 2001, between the Company and The Bank
of New York Mellon Trust Company, N.A. (as successor to The Bank of
New York), as trustee (the Trustee ), as supplemented
by the First Supplemental Indenture, dated as of May 19, 2008,
between the Company and the Trustee (as so supplemented, and
including the terms of the Securities that will be established
pursuant to a company order thereunder, the Indenture
), under which they are to be issued, which is substantially in the
form filed as an exhibit to the Registration Statement; the
Indenture has been duly qualified under the 1939 Act and has been
duly authorized by the Company, and, as of the Time of Delivery,
will be duly executed and delivered by the Company, and will
constitute a valid and legally binding agreement of the Company,
enforceable against the Company in accordance with its terms,
except as may be limited by (i) bankruptcy, insolvency,
fraudulent conveyance, reorganization, moratorium and other similar
laws relating to or affecting creditors’ rights generally,
(ii) general equitable principles (whether considered in a
proceeding in equity or at law) and (iii) concepts of
materiality, reasonableness, good faith and fair dealing and the
discretion of the court before which any matter is brought
(collectively, the Exceptions ); and the Indenture
conforms, and the Securities will conform, in all material
respects, to the descriptions thereof in the Pricing Disclosure
Package and the Prospectus.
(g)
This Agreement has been duly
authorized, executed and delivered by the Company.
(h)
The Company has been duly
incorporated and is validly existing as a corporation in good
standing under the laws of the State of Missouri, with corporate
power and authority to own its properties and conduct its business
as described in the Pricing Prospectus and the Prospectus and to
enter into and perform its obligations under, or as contemplated
by, this Agreement; and the Company is duly qualified to do
business as a foreign corporation in good standing in all other
jurisdictions in which its ownership or lease of property or the
conduct of its business requires such qualification, except to the
extent that the failure to be so qualified or to be in good
standing would not reasonably be expected to have a material
adverse effect on the general affairs, business prospects,
management, financial position, stockholders’ equity or
consolidated results of operations of the Company and its
subsidiaries, taken as a whole (a Material Adverse
Effect ).
(i)
Each significant subsidiary (as
defined in Rule 405 under the 1933 Act) of the Company and
Central Illinois Public Service Company, an Illinois corporation
(each, a Significant Subsidiary ), has been duly
organized and is validly existing in good standing under the laws
of the jurisdiction of its organization, with corporate or limited
liability company power and authority to own its properties and
conduct its business as described in the Pricing Prospectus and the
Prospectus; each such Significant Subsidiary is duly qualified to
do business in good standing in all other jurisdictions in which
its ownership or lease of property or the conduct of its business
requires such qualification, except to the extent that the failure
to be so qualified or to be in good standing would not reasonably
be expected to have a Material Adverse Effect; and all of the
issued and outstanding common stock or other ownership interests of
each Significant Subsidiary has been duly authorized and validly
issued and is fully
4
paid and nonassessable, and all of such common
stock or other ownership interests is owned by the Company,
directly or indirectly, free from liens, encumbrances and defects
of title, except the common stock of Central Illinois Light
Company, which is pledged as security to secure indebtedness of
CILCORP Inc.
(j)
Neither the Company nor any of its
subsidiaries has sustained since the date of the latest audited
consolidated financial statements incorporated by reference in the
Pricing Prospectus and the Prospectus any material loss or
interference with its business from fire, explosion, flood or other
calamity, whether or not covered by insurance, or from any labor
dispute or court or governmental action, order or decree, otherwise
than as set forth or contemplated in the Pricing Prospectus and the
Prospectus; and, since the respective dates as of which information
is given in the Registration Statement, the Pricing Prospectus and
the Prospectus, (i) neither the Company nor any of its
subsidiaries has incurred any liabilities or obligations, direct or
contingent, or entered into any transactions, not in the ordinary
course of business, that are material to the Company and its
subsidiaries, taken as a whole, and (ii) there has not been
any change in the stockholders’ equity (except for regular
quarterly dividends, retained earnings and newly issued shares
issued pursuant to the Company’s dividend reinvestment and
stock purchase plan and the Company’s 401(k) plan), any
increase in long-term debt of the Company or any material adverse
change, or any development involving a prospective material adverse
change, in or affecting the general affairs, management, financial
position, stockholders’ equity or consolidated results of
operations of the Company and its subsidiaries, taken as a whole,
in each case, otherwise than as set forth or contemplated in the
Pricing Prospectus and the Prospectus.
(k)
The issue and sale of the Securities
by the Company, and the compliance by the Company with all of the
provisions of the Securities, the Indenture and this Agreement
applicable to the Company, and the consummation of the transactions
herein and therein contemplated, will not conflict with or result
in a breach or violation of any of the terms or provisions of, or
(with the giving of notice or lapse of time or both) constitute a
default under, any indenture, mortgage, deed of trust, loan
agreement or other agreement or instrument to which the Company or
any of its Significant Subsidiaries is a party or by which the
Company or any of its Significant Subsidiaries is bound or to which
any of the property or assets of the Company or any of its
Significant Subsidiaries is subject, which would reasonably be
expected to have a Material Adverse Effect, nor will such action
result in any violation of the provisions of the articles of
incorporation, by-laws or similar organizational documents of the
Company or any of its Significant Subsidiaries or any statute or
any judgment, order, decree, rule or regulation of any court
or governmental agency or body having jurisdiction over the Company
or any of its Significant Subsidiaries or any of their properties;
the execution, delivery and performance of the Securities, the
Indenture and this Agreement and the consummation of the
transactions herein and therein contemplated will not require the
approval or consent of any holder or trustee of any debt or other
obligations or securities of the Company which will not have been
obtained; and no consent, approval, authorization, order,
registration, filing or qualification of or with any court or
governmental agency or body is required for the issue and sale of
the Securities by the Company, or the consummation by the Company
of the transactions contemplated by this Agreement or the
Indenture, except such as have been obtained under the 1933 Act and
the 1939 Act and such consents, approvals, authorizations, orders,
registrations, filings or qualifications as may be required under
state securities or blue sky laws of any jurisdiction in connection
with the purchase and distribution of the Securities by the
Underwriters.
5
(l)
The Company has an authorized
capitalization as set forth in the Pricing Prospectus and the
Prospectus and all of the issued shares of capital stock of the
Company have been duly and validly authorized and issued and are
fully paid and non-assessable.
(m)
Neither the Company nor any of its
Significant Subsidiaries is (i) in violation of its articles
of incorporation, by-laws or similar organizational documents,
(ii) to the best knowledge of the Company, after due inquiry,
other than as set forth in the Pricing Prospectus and the
Prospectus, in violation of any law, ordinance, administrative or
governmental rule or regulation applicable to the Company or
its Significant Subsidiaries, the violation of which would
reasonably be expected to have a Material Adverse Effect, or of any
decree of any court or governmental agency or body having
jurisdiction over the Company or such Significant Subsidiaries, or
(iii) in default in the performance or observance of any
obligation, agreement, covenant or condition contained in any
indenture, mortgage, deed of trust, loan agreement, lease or other
agreement or instrument to which it is a party or by which it or
any of its properties may be bound, which default would reasonably
be expected to have a Material Adverse Effect.
(n)
Other than as set forth in the
Pricing Prospectus and the Prospectus, there are no legal or
governmental proceedings pending to which the Company or any of its
Significant Subsidiaries is a party or of which any property of the
Company or any of its Significant Subsidiaries is the subject that,
if determined adversely to the Company or that Significant
Subsidiary, would individually or in the aggregate reasonably be
expected to have a Material Adverse Effect, and, to the
Company’s knowledge, no such proceedings are threatened
by governmental authorities or others.
(o)
The statements set forth in the
Pricing Prospectus and the Prospectus under the captions
“Description of Senior Notes” and “Description of
Debt Securities,” insofar as they purport to constitute a
summary of the terms of the Securities and the Indenture, under the
caption “Material United States Federal Income Tax
Consequences” and under the captions
“Underwriting” and “Plan of Distribution,”
insofar as they purport to describe the provisions of the laws and
documents referred to therein, are accurate, complete and
fair.
(p)
The consolidated financial
statements of the Company incorporated by reference in the
Registration Statement, the Pricing Prospectus and the Prospectus
have been prepared in conformity with generally accepted accounting
principles in the United States and fairly present the financial
position of the Company as of the dates set forth
therein.
(q)
PricewaterhouseCoopers LLP (the
Accountants ), who have audited certain financial
statements of the Company and its subsidiaries, and have audited
the Company’s internal control over financial reporting, is
an independent registered public accounting firm with respect to
the Company as required by the 1933 Act and the rules and
regulations of the SEC thereunder and the Public Company Accounting
Oversight Board (United States).
(r)
The Company is not, and, after
giving effect to the offering and sale of the Securities and the
application of the proceeds thereof, will not be, an
“investment company,” or an entity
“controlled” by an investment company, as such terms
are defined in the Investment Company Act of 1940, as
amended.
(s)
Except as set forth in the Pricing
Prospectus and the Prospectus, each of the Company and its
Significant Subsidiaries (i) is in compliance with any and all
applicable
6
federal, state and local laws and regulations
relating to the protection of human health and safety, the
environment or hazardous or toxic substances or wastes, pollutants
or contaminants ( Environmental Laws ), (ii) has
received all permits, licenses or other approvals required of it
under applicable Environmental Laws to conduct its business and
(iii) is in compliance with all terms and conditions of any
such permit, license or approval, except where such non-compliance
with Environmental Laws or failure to receive, or comply with the
terms and conditions of required permits, licenses or other
approvals, would not, singly or in the aggregate, reasonably be
expected to have a Material Adverse Effect.
(t)
The Company maintains a system of
internal control over financial reporting (as such term is defined
in Rule 13a-15(f) under the 1934 Act) that complies with
the requirements of the 1934 Act and has been designed by the
Company’s principal executive officer and principal financial
officer, or under their supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in
accordance with generally accepted accounting principles.
Except as disclosed in the Pricing Prospectus and the Prospectus,
the Company’s internal control over financial reporting as of
March 31, 2009 was effective and the Company is not aware of
any material weaknesses in its internal control over financial
reporting since that date.
(u)
Except as disclosed in the Pricing
Prospectus and the Prospectus, since March 31, 2009, to the
knowledge of the Controller of Ameren Corporation, there has been
no change in the Company’s internal control over financial
reporting that has materially affected, or is reasonably likely to
materially affect, the Company’s internal control over
financial reporting.
(v)
The Company maintains disclosure
controls and procedures (as such term is defined in
Rule 13a-15(e) under the 1934 Act) that comply with the
requirements of the 1934 Act; such disclosure controls and
procedures have been designed to ensure that material information
relating to the Company and its subsidiaries is made known to the
Company’s principal executive officer and principal financial
officer by others within those entities; such disclosure controls
and procedures as of March 31, 2009 were effective; and since
March 31, 2009, to the knowledge of the Controller of Ameren
Corporation, there has been no change in the Company’s
disclosure controls and procedures that has materially affected, or
is reasonably likely to materially affect, the Company’s
disclosure controls and procedures.
(w)
(A) (i) At the time of
initial filing of the Registration Statement, (ii) at the time
of the most recent amendment thereto for the purposes of complying
with Section 10(a)(3) of the 1933 Act (whether such
amendment was by post-effective amendment, incorporated report
filed pursuant to Section 13 or 15(d) of the 1934 Act or
form of prospectus), and (iii) at the time the Company or any
person acting on its behalf (within the meaning, for this clause
only, of Rule 163(c) under the 1933 Act) made any offer
relating to the Securities in reliance on the exemption of
Rule 163 under the 1933 Act, the Company was a
“well-known seasoned issuer” as defined in
Rule 405 under the 1933 Act; and (B) at the earliest time
after the filing of the Registration Statement that the Company or
another offering participant made a bona fide offer (within the
meaning of Rule 164(h)(2) under the 1933 Act) of the
Securities, the Company was not, and currently is not, an
“ineligible issuer” as defined in Rule 405 under
the 1933 Act.
2.
Subject to the terms and conditions
herein set forth, the Company agrees to issue and sell to each of
the Underwriters, and each of the Underwriters agrees, severally
and not jointly, to purchase from the Company, at a purchase price
of 98.905% of the principal amount thereof, the principal amount of
Securities set forth opposite the name of such Underwriter in
Schedule I hereto.
7
3.
Upon the authorization by the
Representatives of the release of the Securities, the several
Underwriters propose to offer the Securities for sale upon the
terms and conditions set forth in the Prospectus.
4.
(a)
The Securities to be purchased by
each Underwriter hereunder will be represented by one or more
definitive global Securities in book-entry form which will be
deposited by or on behalf of the Company with The Depository Trust
Company ( DTC ) or its designated custodian.
The Company will deliver the Securities to the Representatives, for
the account of each Underwriter, against payment by or on
behalf of such Underwriter of the purchase price therefor by wire
transfer of Federal (same-day) funds to the account specified by
the Company to the Representatives at least forty-eight hours in
advance, by causing DTC to credit the Securities to the account of
UBS Securities LLC at DTC. The Company will cause the
certificates representing the Securities to be made available to
the Representatives for checking at least twenty-four hours prior
to the Time of Delivery (as defined below) at the Closing Location
(as defined below). The time and date of such delivery and
payment shall be 10:00 a.m., New York City time, on
May 15, 2009 or such other time and date as the
Representatives and the Company may agree upon in writing.
Such time and date are herein called the Time of
Delivery .
(b)
The documents to be delivered at the
Time of Delivery by or on behalf of the parties hereto pursuant to
Section 8 hereof, including the cross-receipt for the
Securities and any additional documents requested by Pillsbury
Winthrop Shaw Pittman LLP, New York, New York (
Underwriters’ Counsel ) pursuant to
Section 8(k) hereof, will be delivered at the office of
Morgan, Lewis & Bockius LLP, special counsel to the
Company, 101 Park Avenue, New York, New York 10178 (the
Closing Location ), all at the Time of
Delivery. A meeting will be held at the Closing Location at
3:00 p.m., New York City time, on the New York Business Day
next preceding the Time of Delivery, at which meeting the final
drafts of the documents to be delivered pursuant to the preceding
sentence will be available for review by the parties hereto.
For the purposes of this Section 4, New York Business
Day shall mean each Monday, Tuesday, Wednesday, Thursday
and Friday which is not a day on which banking institutions in New
York City are generally authorized or obligated by law or executive
order to close.
5.
The Company agrees with each of the
Underwriters:
(a)
To prepare the Prospectus in a form
approved by the Representatives and to file such Prospectus
pursuant to Rule 424(b) and Rule 430A,
Rule 430B or Rule 430C under the 1933 Act not later than
the SEC’s close of business on the second business day
following the execution and delivery of this Agreement or, if
applicable, such earlier time as may be required by
Rule 424(b) under the 1933 Act; to make no further
amendment (except the final term sheet referred to below) or any
supplement to the Registration Statement, the Pricing Prospectus,
any Issuer Free Writing Prospectus or the Prospectus prior to the
Time of Delivery which shall be disapproved by the Representatives
promptly after reasonable notice thereof; to advise the
Representatives, promptly after it receives notice thereof, of the
time when any amendment to the Registration Statement has been
filed or becomes effective or any amendment or supplement to the
Prospectus has been filed with the SEC and to furnish the
Representatives with copies thereof; to prepare a final term sheet
in the form attached as Exhibit A to Schedule II hereto and to
file such final term sheet pursuant to Rule 433(d) under
the 1933 Act within the time required by such Rule; to file
promptly all other material required to be filed by the Company
with the SEC pursuant to Rule 433(d) under the 1933 Act;
to file promptly all reports and any definitive proxy or
information statements required to be filed by the
8
Company with the SEC pursuant to
Section 13(a), 13(c), 14 or 15(d) of the 1934 Act
subsequent to the date of the Prospectus and for so long as the
delivery of a prospectus (or in lieu thereof, the notice referred
to in Rule 173(a) under the 1933 Act) is required in
connection with the offering or sale of the Securities; to promptly
notify the Underwriters of any written notice given to the Company
by any “nationally recognized statistical rating
organization” within the meaning of
Rule 436(g)(2) under the 1933 Act (a Rating
Agency ) of any intended decrease in any rating of any
securities of the Company or of any intended change in any such
rating that does not indicate the direction of the possible change
of any such rating, in each case by any such Rating Agency; to
advise the Representatives, promptly after it receives notice
thereof, of the issuance by the SEC of any stop order or of any
order preventing or suspending the use of any Preliminary
Prospectus or other prospectus in respect of the Securities, of the
suspension of the qualification of the Securities for offering or
sale in any jurisdiction, of the initiation or threatening of any
proceeding for any such purpose or pursuant to Section 8A of
the 1933 Act against the Company or relating to the offering of the
Securities, or of any request by the SEC for the amending or
supplementing of the Registration Statement or the Prospectus or
for additional information; and, in the event of the issuance of
any such stop order or of any such order preventing or suspending
the use of any Preliminary Prospectus or other prospectus relating
to the Securities or suspending any such qualification, to promptly
use its best efforts to obtain the withdrawal of such
order.
(b)
If at any time prior to the Time of
Delivery (A) any event shall occur or condition shall exist as
a result of which the Pricing Disclosure Package as then amended or
supplemented would include any untrue statement of a material fact
or omit to state any material fact necessary in order to make the
statements therein, in the light of the circumstances under which
they were made, not misleading or (B) it is necessary to amend
or supplement the Pricing Disclosure Package to comply with law,
the Company will immediately notify the Representatives thereof and
forthwith prepare and file with the SEC (to the extent required)
and furnish to the Underwriters and to such dealers as the
Representatives may designate, such amendments or supplements to
the Pricing Disclosure Package as may be necessary so that the
statements in the Pricing Disclosure Package as so amended or
supplemented will not, in the light of the circumstances under
which they were made, be misleading or so that the Pricing
Disclosure Package will comply with law.
(c)
For so long as the delivery of a
prospectus (or in lieu thereof, the notice referred to in
Rule 173(a) under the 1933 Act) is required in connection
with the offering or sale of the Securities, to furnish such proper
information as may be lawfully required and otherwise cooperate in
qualifying the Securities for offer and sale under the securities
or blue sky laws of such jurisdictions as the Representatives may
reasonably designate and will file and make in each year such
statements or reports as are or may be reasonably required by the
laws of such jurisdictions; provided, however , that the
Company shall not be required to qualify as a foreign corporation,
qualify as a dealer in securities or file a general consent to
service of process under the laws of any jurisdiction.
(d)
If immediately prior to the third
anniversary (the “Renewal Deadline”) of the initial
effective date of the Registration Statement, any of the Securities
remain unsold by the Underwriters, the Company will, prior to the
Renewal Deadline, file, if it has not already done so and is
eligible to do so, a new automatic shelf registration statement
relating to the Securities, in a form satisfactory to the
Representatives. If the Company is no longer eligible to file
an automatic shelf registration statement, the Company will, prior
to the Renewal Deadline, if it has not already done so, file a new
shelf registration statement relating to the Securities, in a form
satisfactory to the Representatives, and will use its best efforts
to cause such registration
9
statement to be declared effective within
180 days after the Renewal Deadline. The Company will
take all other action necessary or appropriate to permit the public
offering and sale of the Securities to continue as contemplated in
the expired registration statement relating to the Securities.
References herein to the Registration Statement shall include such
new automatic shelf registration statement or such new shelf
registration statement, as the case may be.
(e)
If at any time when the Securities
remain unsold by the Underwriters the Company receives from the SEC
a notice pursuant to Rule 401(g)(2) under the 1933 Act or
otherwise ceases to be eligible to use the automatic shelf
registration statement form, the Company will (i) promptly
notify the Representatives, (ii) promptly file a new
registration statement or post-effective amendment on the proper
form relating to the Securities, in a form satisfactory to the
Representatives, (iii) use its best efforts to cause such
registration statement or post-effective amendment to be declared
effective and (iv) promptly notify the Representatives of such
effectiveness. The Company will take all other action
necessary or appropriate to permit the public offering and sale of
the Securities to continue as contemplated in the registration
statement that was the subject of the
Rule 401(g)(2) notice or for which the Company has
otherwise become ineligible. References herein to the
Registration Statement shall include such new registration
statement or post-effective amendment, as the case may
be.
(f)
Prior to 10:00 a.m., New York
City time, on the New York Business Day next succeeding the date of
this Agreement and from time to time, to furnish the Underwriters
with written and electronic copies of the Prospectus and each
Issuer Free Writing Prospectus (to the extent not previously
delivered), as amended or supplemented, in New York City in such
quantities as the Representatives may reasonably request, and, if
the delivery of a prospectus (or in lieu thereof, the notice
referred to in Rule 173(a) under the 1933 Act) is
required at any time in connection with the offering or sale of the
Securities and if at such time any event shall have occurred as a
result of which the Prospectus, the Pricing Disclosure Package or
any Issuer Free Writing Prospectus as then amended or supplemented
would include an untrue statement of a material fact or omit to
state any material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were
made when such Prospectus (or in lieu thereof, the notice referred
to in Rule 173(a) under the 1933 Act), such Pricing
Disclosure Package or such Issuer Free Writing Prospectus as then
amended or supplemented is delivered, not misleading, or, if for
any other reason it shall be necessary during such same period to
amend or supplement the Prospectus or to file under the 1934 Act
any document incorporated by reference in the Prospectus in order
to comply with the 1933 Act, the 1934 Act or the 1939 Act, to
notify the Representatives and upon their request to file such
document and to prepare and furnish without charge to each
Underwriter and to any dealer in securities as many written and
electronic copies as the Representatives may from time to time
reasonably request of an amended Prospectus or a supplement to the
Prospectus which will correct such statement or omission or effect
such compliance, or, if at any time prior to the Time of Delivery
(i) any event shall occur or condition shall exist as a result
of which the Pricing Disclosure Package as then amended or
supplemented would include any untrue statement of a material fact
or omit to state any material fact necessary in order to make the
statements therein, in the light of the circumstances, not
misleading or (ii) it is necessary to amend or supplement the
Pricing Disclosure Package to comply with law, the Company will
immediately notify the Underwriters thereof and forthwith prepare
and, subject to Section 5(a) above, file with the SEC (to
the extent required) and furnish to the Underwriters and to such
dealers as the Representatives may designate, such amendments or
supplements to the Pricing Disclosure Package as may be necessary
so that the statements in the Pricing Disclosure Package as so
amended or supplemented will not, in the light of the
circumstances, be misleading or so that the Pricing Disclosure
Package will comply with law; and in case any Underwriter is
required to
10
deliver a prospectus (or in lieu thereof, the
notice referred to in Rule 173(a) under the 1933 Act) in
connection with sales of any of the Securities at any time nine
months or more after the time of issue of the Prospectus, upon the
Representatives’ request but at the expense of such
Underwriter, to prepare and deliver to such Underwriter as many
written and electronic copies as the Representatives may request of
an amended or supplemented Prospectus complying with
Section 10(a)(3) of the 1933 Act.
(g)
In accordance with Rule 158
under the 1933 Act, to make generally available to its security
holders and to holders of the Securities, as soon as practicable,
but in any event not later than eighteen months after the effective
date of the Registration Statement (as defined in
Rule 158(c) under the 1933 Act), an earning statement of
the Company (which need not be audited) complying with
Section 11(a) of the 1933 Act and the rules and
regulations of the SEC thereunder (including, at the option of the
Company, Rule 158 under the 1933 Act).
(h)
During the period beginning from the
date hereof and continuing to and including the later of
(i) the termination of trading restrictions for the
Securities, as notified to the Company by t